Katina Dorton

Insider Reports History

Location
Boise, ID
Signature
/s/ Mark Tyndall, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Katina Dorton:

Company Role Class Num Shares Value Price $ Report Date Ownership
Keenova Therapeutics plc Director Ordinary Shares 2,505 $222,319 $88.75 01 Jan 2026 Direct
Prelude Therapeutics Inc Director Director Stock Option (Right to Buy) 76,000 17 Oct 2025 Direct
TScan Therapeutics, Inc. Director Stock Option (Right to Buy) 67,000 30 Jun 2025 Direct
Fulcrum Therapeutics, Inc. Director Stock Option (right to buy) 36,000 26 Jun 2025 Direct
Keenova Therapeutics plc Director Restricted Stock Units 27,898 01 Jan 2026 Direct
US Ecology, Inc. Director Common Stock 0 $48.00 02 May 2022 Direct
US Ecology, Inc. Director Common Stock 0 $48.00 02 May 2022 Retirement Account

Insider Reports Filed by Katina Dorton

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465926000779-dorton-katina-2026-01-01 Keenova Therapeutics plc 01 Jan 2026 4 $0 4 Director 05 Jan 2026, 18:00
PRLD Prelude Therapeutics Inc 17 Oct 2025 1 $0 4 Director 20 Oct 2025, 16:16
PRLD Prelude Therapeutics Inc 17 Oct 2025 0 $0 3 Director 20 Oct 2025, 16:01
/report/000110465925079943-dorton-katina-2025-08-14 Mallinckrodt plc 14 Aug 2025 1 $0 4 Director 18 Aug 2025, 21:03
/report/000110465925073790-dorton-katina-2025-07-31 Mallinckrodt plc 31 Jul 2025 1 $0 4 Director 04 Aug 2025, 20:50
TCRX TScan Therapeutics, Inc. 30 Jun 2025 1 $0 4 Director 02 Jul 2025, 16:26
FULC Fulcrum Therapeutics, Inc. 26 Jun 2025 1 $0 4 Director 30 Jun 2025, 16:15
/report/000110465925000367-dorton-katina-2025-01-01 Mallinckrodt plc 01 Jan 2025 4 $0 4 Director 02 Jan 2025, 17:00
FULC Fulcrum Therapeutics, Inc. 17 Jun 2024 1 $0 4 Director 18 Jun 2024, 16:20
TCRX TScan Therapeutics, Inc. 12 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:20
/report/000110465924025519-dorton-katina-2024-02-19 Mallinckrodt plc 19 Feb 2024 1 $0 4 Director 20 Feb 2024, 16:11
/report/000110465924016854-dorton-katina-2024-02-02 Mallinckrodt plc 02 Feb 2024 0 $0 3 Director 12 Feb 2024, 21:55
FULC Fulcrum Therapeutics, Inc. 27 Jun 2023 1 $0 4 Director 29 Jun 2023, 16:16
TCRX TScan Therapeutics, Inc. 13 Jun 2023 1 $0 4 Director 15 Jun 2023, 18:17
FULC Fulcrum Therapeutics, Inc. 27 Jun 2022 1 $0 4 Director 29 Jun 2022, 17:00
TCRX TScan Therapeutics, Inc. 01 Jun 2022 1 $0 4 Director 03 Jun 2022, 16:30
/report/000143774922010680-dorton-katina-2022-05-02 US Ecology, Inc. 02 May 2022 2 -$648,000 4 Director 03 May 2022, 16:29
TCRX TScan Therapeutics, Inc. 15 Jul 2021 0 $0 3 Director 15 Jul 2021, 18:13
FULC Fulcrum Therapeutics, Inc. 09 Jun 2021 1 $0 4 Director 11 Jun 2021, 17:10
/report/000143774921013676-dorton-katina-2021-05-26 US Ecology, Inc. 26 May 2021 1 $0 4 Director 28 May 2021, 13:02